0 false false false false false false false false false true false false false false false false No description of principal activity 2022-11-01 Sage Accounts Production Advanced 2021 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 13689734 2022-11-01 2023-10-31 13689734 2023-10-31 13689734 2022-10-31 13689734 2021-10-19 2022-10-31 13689734 2022-10-31 13689734 bus:Director1 2022-11-01 2023-10-31 13689734 bus:Director2 2022-11-01 2023-10-31 13689734 core:WithinOneYear 2023-10-31 13689734 core:WithinOneYear 2022-10-31 13689734 core:AfterOneYear 2023-10-31 13689734 core:AfterOneYear 2022-10-31 13689734 core:RestatedAmount 2022-10-31 13689734 bus:Director1 2022-10-31 13689734 bus:Director1 2023-10-31 13689734 bus:Director2 2022-10-31 13689734 bus:Director2 2023-10-31 13689734 bus:Director1 2022-10-31 13689734 bus:Director2 2022-10-31 13689734 bus:Director1 2021-10-19 2022-10-31 13689734 bus:Director2 2021-10-19 2022-10-31 13689734 bus:Micro-entities 2022-11-01 2023-10-31 13689734 bus:AuditExempt-NoAccountantsReport 2022-11-01 2023-10-31 13689734 bus:FullAccounts 2022-11-01 2023-10-31 13689734 bus:SmallCompaniesRegimeForAccounts 2022-11-01 2023-10-31 13689734 bus:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31
COMPANY REGISTRATION NUMBER: 13689734
Principle Health Ltd
Filleted Unaudited Financial Statements
31 October 2023
Principle Health Ltd
Statement of Financial Position
31 October 2023
Period from
Year to
19 Oct 21 to
31 Oct 23
31 Oct 22
£
£
Fixed assets
256
511
----
----
Current assets
2,869
5,504
Creditors: amounts falling due within one year
2,017
2,243
-------
-------
Net current assets
852
3,261
-------
-------
Total assets less current liabilities
1,108
3,772
Creditors: amounts falling due after more than one year
9,500
6,000
Accruals and deferred income
2,587
1,861
--------
-------
(10,979)
(4,089)
--------
-------
Capital and reserves
( 10,979)
( 4,089)
--------
-------
Notes to the financial statements
1. Directors' advances, credits and guarantees
During the year the directors entered into the following advances and credits with the company:
2023
Balance brought forward
Advances/ (credits) to the directors
Amounts repaid
Balance outstanding
£
£
£
£
Dr A Kaur
( 5,206)
( 1,750)
226
( 6,730)
Dr F Noorani
( 3,037)
( 1,750)
( 4,787)
-------
-------
----
--------
( 8,243)
( 3,500)
226
( 11,517)
-------
-------
----
--------
2022
Balance brought forward
Advances/ (credits) to the directors
Amounts repaid
Balance outstanding
£
£
£
£
Dr A Kaur
( 5,206)
( 5,206)
Dr F Noorani
( 3,037)
( 3,037)
----
-------
----
-------
( 8,243)
( 8,243)
----
-------
----
-------
For the year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 30 July 2024 , and are signed on behalf of the board by:
Dr A Kaur
Director
Company registration number: 13689734
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 9A Loveday Road, London, W13 9JT.